We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
-12.93%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$102B
AUM Growth
-$16.3B
Cap. Flow
+$749M
Cap. Flow %
0.73%
Top 10 Hldgs %
23.72%
Holding
4,322
New
210
Increased
1,790
Reduced
1,850
Closed
304
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GFI icon
2876
Gold Fields
GFI
$35.4B
$531K ﹤0.01%
58,224
+20,654
+55% +$247K
SPXX icon
2877
Nuveen S&P 500 Dynamic Overwrite Fund
SPXX
$344M
$531K ﹤0.01%
33,932
-10,713
-24% -$176K
XRX icon
2878
Xerox
XRX
$412M
$531K ﹤0.01%
35,742
+2,414
+7% +$42.8K
MTTR
2879
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$531K ﹤0.01%
145,192
+19,610
+16% +$107K
HIX
2880
Western Asset High Income Fund II
HIX
$355M
$530K ﹤0.01%
107,521
+167
+0.2% +$889
SPHY icon
2881
State Street SPDR Portfolio High Yield Bond ETF
SPHY
$12.1B
$530K ﹤0.01%
23,613
-1,881
-7% -$44.7K
AMRX icon
2882
Amneal Pharmaceuticals
AMRX
$6.15B
$528K ﹤0.01%
165,973
-2,000
-1% -$7.25K
WOR icon
2883
Worthington Enterprises
WOR
$2.78B
$527K ﹤0.01%
19,386
-539
-3% -$15.6K
NAPA
2884
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
$527K ﹤0.01%
25,033
-351
-1% -$6.89K
IDLV icon
2885
Invesco S&P International Developed Low Volatility ETF
IDLV
$343M
$526K ﹤0.01%
19,045
-58,476
-75% -$1.73M
GRFS
2886
Grifois
GRFS
$5.4B
$524K ﹤0.01%
44,147
+30,597
+226% +$365K
NRIX icon
2887
Nurix Therapeutics
NRIX
$2.76B
$523K ﹤0.01%
+41,279
New +$468K
RRR icon
2888
Red Rock Resorts
RRR
$3.73B
$521K ﹤0.01%
15,626
-11,286
-42% -$451K
CPK icon
2889
Chesapeake Utilities
CPK
$3.25B
$520K ﹤0.01%
4,011
+46
+1% +$6K
GNMA icon
2890
iShares GNMA Bond ETF
GNMA
$433M
$519K ﹤0.01%
11,403
-1,140
-9% -$52.4K
BCLI
2891
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$517K ﹤0.01%
12,494
-200
-2% -$9.01K
DASH icon
2892
DoorDash
DASH
$92.1B
$517K ﹤0.01%
8,055
+1,769
+28% +$140K
CYRX icon
2893
CryoPort
CYRX
$766M
$516K ﹤0.01%
16,666
-472
-3% -$12.6K
CANO
2894
DELISTED
Cano Health, Inc.
CANO
$516K ﹤0.01%
1,178
-78
-6% -$40.7K
GTX icon
2895
Garrett Motion
GTX
$5.47B
$514K ﹤0.01%
66,540
-2,578
-4% -$17.4K
NETI
2896
DELISTED
Eneti Inc.
NETI
$514K ﹤0.01%
83,724
-73,159
-47% -$469K
AUY
2897
DELISTED
Yamana Gold, Inc.
AUY
$512K ﹤0.01%
110,018
+887
+0.8% +$4.81K
BGT icon
2898
BlackRock Floating Rate Income Trust
BGT
$330M
$511K ﹤0.01%
46,367
+14,367
+45% +$167K
JPUS
2899
JPMorgan Diversified Return US Equity ETF
JPUS
$468M
$511K ﹤0.01%
5,586
-41
-0.7% -$4.06K
RGNX icon
2900
Regenxbio
RGNX
$720M
$511K ﹤0.01%
20,683
+3,100
+18% +$77.4K

Similar funds

Raymond James & Associates's Q2 2022 Portfolio in Review

As of Q2 2022, Raymond James & Associates held 4,322 positions worth $102B, down 14% from $119B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates's Q2 2022 filing shows 210 new, 1,790 increased, 1,850 reduced and 304 closed positions. Its largest new stake was Aspen Technology Inc: 54,037 shares worth $9.93M. The largest sale was iShares Core MSCI EAFE ETF, an estimated $551M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q2 2022 buy was Aspen Technology Inc: 54,037 shares worth $9.93M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2022, an estimated $471M increase.
  • Raymond James & Associates's biggest Q2 2022 reduction was iShares Core MSCI EAFE ETF, cutting an estimated $551M.
  • Raymond James & Associates fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $21.5M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $102B portfolio in Q2 2022.
  • Raymond James & Associates opened 210 new positions and closed 304 in Q2 2022.
  • Raymond James & Associates's portfolio value fell 14% quarter-over-quarter to $102B.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.